4//SEC Filing
Wedel Mark K 4
Accession 0000874015-06-000003
CIK 0000874015other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:21 PM ET
Size
7.9 KB
Accession
0000874015-06-000003
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2006-01-03+25,784→ 25,784 totalExercise: $5.25From: 2007-01-03Exp: 2013-01-02→ Common Stock (25,784 underlying) - Other
Common Stock
2006-01-01$3.36/sh+394$1,323→ 8,454 total
Footnotes (2)
- [F1]Reporting 394 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on January 1, 2006.
- [F2]Grant of 1-3-06 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-3-07. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 6,446 shares per year. The option is exercisable as to 0 shares on 1-3-06.
Documents
Issuer
ISIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001321261
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:21 PM ET
- Size
- 7.9 KB